Edition:
United States

Dicerna Pharmaceuticals Inc (DRNA.O)

DRNA.O on Nasdaq

12.77USD
23 Aug 2019
Change (% chg)

$-0.28 (-2.15%)
Prev Close
$13.05
Open
$12.96
Day's High
$13.31
Day's Low
$12.70
Volume
389,350
Avg. Vol
400,493
52-wk High
$17.98
52-wk Low
$9.31

About

Dicerna Pharmaceuticals, Inc. is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based on its RNA interference (RNAi) technology platform. It is focused on development of RNAi-based therapeutics using its GalXC RNAi... (more)

Overall

Beta: 2.11
Market Cap(Mil.): $951.07
Shares Outstanding(Mil.): 68.32
Dividend: --
Yield (%): --

Financials

  DRNA.O Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.70 -- --
ROI: -49.87 7.52 12.69
ROE: -74.34 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates